195 related articles for article (PubMed ID: 38880655)
1. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: Ligand Search and Screening.
Luginina AP; Khnykin AN; Khorn PA; Moiseeva OV; Safronova NA; Pospelov VA; Dashevskii DE; Belousov AS; Borschevskiy VI; Mishin AV
Biochemistry (Mosc); 2024 May; 89(5):958-972. PubMed ID: 38880655
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Drugs Targeting G-Protein-Coupled Receptors: A Structural Biology Perspective.
Khorn PA; Luginina AP; Pospelov VA; Dashevsky DE; Khnykin AN; Moiseeva OV; Safronova NA; Belousov AS; Mishin AV; Borshchevsky VI
Biochemistry (Mosc); 2024 Apr; 89(4):747-764. PubMed ID: 38831510
[TBL] [Abstract][Full Text] [Related]
3. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
Lee Y; Basith S; Choi S
J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
Bhunia SS; Saxena AK
Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
[TBL] [Abstract][Full Text] [Related]
6. Chemical Diversity in the G Protein-Coupled Receptor Superfamily.
Vass M; Kooistra AJ; Yang D; Stevens RC; Wang MW; de Graaf C
Trends Pharmacol Sci; 2018 May; 39(5):494-512. PubMed ID: 29576399
[TBL] [Abstract][Full Text] [Related]
7. Structure-based and fragment-based GPCR drug discovery.
Andrews SP; Brown GA; Christopher JA
ChemMedChem; 2014 Feb; 9(2):256-75. PubMed ID: 24353016
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
[TBL] [Abstract][Full Text] [Related]
9. From three-dimensional GPCR structure to rational ligand discovery.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
[TBL] [Abstract][Full Text] [Related]
10. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
Lee Y; Lazim R; Macalino SJY; Choi S
Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
[TBL] [Abstract][Full Text] [Related]
11. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
Lee SM; Booe JM; Pioszak AA
Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
[TBL] [Abstract][Full Text] [Related]
13. Multiscale Molecular Modeling in G Protein-Coupled Receptor (GPCR)-Ligand Studies.
Nakliang P; Lazim R; Chang H; Choi S
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32325877
[TBL] [Abstract][Full Text] [Related]
14. Chemogenomics approaches to G-protein coupled receptor lead finding.
Klabunde T; Jäger R
Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
[TBL] [Abstract][Full Text] [Related]
15. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
Dunn HA; Orlandi C; Martemyanov KA
Pharmacol Rev; 2019 Oct; 71(4):503-519. PubMed ID: 31515243
[TBL] [Abstract][Full Text] [Related]
16. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
Ferré S; Casadó V; Devi LA; Filizola M; Jockers R; Lohse MJ; Milligan G; Pin JP; Guitart X
Pharmacol Rev; 2014; 66(2):413-34. PubMed ID: 24515647
[TBL] [Abstract][Full Text] [Related]
18. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
Chan WKB; Zhang Y
J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
[TBL] [Abstract][Full Text] [Related]
19. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
Rodríguez D; Gutiérrez-de-Terán H
Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
[TBL] [Abstract][Full Text] [Related]
20. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
